which also donated the colostrum for the study. Biofiber-Damino had no role in the design, analysis or writing of this article. University of Copenhagen has filed a patent application regarding the use of bovine colostrum for paediatric patients. Per Sangild is listed as sole inventor but has declined Abstract Objective: Feeding bovine colostrum (BC) improves gut maturation and function, and protects against necrotizing enterocolitis (NEC), relative to formula in newborn preterm pigs. Before BC can be used for preterm infants, it is important to test if the milk processing, required to reduce bacterial load and increase shelf life, may affect bioactivity and efficacy of a BC product.
Introduction
Colostrum is rich in bioactive factors compared with mature milk, which are essential in stimulating gastrointestinal and immunological maturation, and a favourable gut microbiota (1) (2) (3) (4) (5) . Colostrum may be particularly important for compromised preterm neonates, as their intestinal immaturity may lead to maldigestion, bacterial dyscolonisation and dys-regulated immune responses, which potentially can lead to necrotising enterocolitis (NEC). Feeding bovine colostrum (BC), mature milk or human donor milk improves gut development and NEC protection in preterm pigs, compared with formula (6) (7) (8) , with minimal NEC symptoms when BC is fed in slowly advancing volumes from birth (9, 10) . Likewise, preterm infants fed mother's own milk have a reduced risk of NEC, compared with preterm infants fed formula, also when combined with human donor milk (11) (12) (13) (14) . Mother's milk is often absent or limited during the first critical days after birth (14) , and in this situation, BC could be an alternative to formula that lacks important bioactive components.
Preliminary studies show that raw and reconstituted BC powder is well-tolerated by children with short bowel syndrome (15) and newborn preterm infants (16) , respectively. However, the efficacy of BC products in response to different milk processing conditions, and relative to formula products, is difficult to assess in infants. Heat treatment, including spray drying and pasteurisation, increases shelf life, reduces bacterial load, and facilitates handling of BC products, but it may also affect its bioactivity due to loss or reduction of bioactive factors. Gentle heat treatment of milk whey protein concentrate has shown to preserve bioactive factors and improve gut development in preterm pigs, although the products based on mature bovine milk remain inferior to BC (17) .
We hypothesised that spray drying and pasteurisation would not markedly affect the beneficial effects of BC on the immature intestine, compared with formula. This was investigated in a preterm pig model of NEC, investigating intestinal structure and functions, microbiota, and tissue protein and mRNA levels of immune factors. An in vitro cell migration assay was used to determine wound healing in the presence of increasing doses of the three BC products. Finally, the concentration of some bioactive proteins and treatment-related aggregation of proteins in the BC products were determined.
Methods

Animal procedures
Forty-five preterm pigs were delivered from four sows (Large White × Danish Landrace × Duroc) by caesarean section at 105-107 d of gestation (90-92% gestation). The procedures for caesarean section and nursing of the preterm pigs followed a standard protocol (18) . Each pig received intraarterial infusions of maternal porcine plasma at 3, 8 and 12 h after birth (4, 5, and 7 ml/kg body weight (BW), respectively) to provide passive immunity. The pigs were given total parenteral nutrition (TPN) for 48 h based on Nutriflex Lipid Plus (Braun, Melsungen, Germany; 4 ml/kg advancing to 6 ml/kg per h) adjusted in composition to meet the nutritional requirements of the preterm pigs (18) . Hereafter, the pigs were given total enteral nutrition for 2 d before euthanasia and tissue collection. During the first 6 h of enteral feeding, all pigs received formula (80 g Pepdite, 70
g Maxipro, and 75 g Liquigen per litre of water (18) , kindly donated by Nutricia, Allerød, Denmark). Hereafter, the pigs were allocated according to birth weight into the four enteral nutrition groups (feeding dose, 15 ml/kg BW/3 h): BC (COLOS, n = 14), reconstituted spray dried BC (POW, n = 8), reconstituted, pasteurised and spray dried BC (POWPAS, n = 9), or formula (FORM, n = 14). Collectively, pigs fed COLOS, POW or POWPAS are abbreviated BC pigs. The BC products were produced from the same batch of first milking after parturition and kindly donated by Biofiber-Damino, Gesten, Denmark. Pasteurisation of liquid BC was performed at 72°C for 15 s and spray drying was performed by filter mat spray drying (confidential procedure, Biofiber-Damino). COLOS, POW and POWPAS were sterilised by irradiation (1 x 10 kGy, Sterigenics, Espergaerde, Denmark), to ensure that all BC products were completely free of bacterial activity. This was tested using C-calves blood agar (SSI Diagnostica, Hillerød, Denmark) under anaerobic and aerobic conditions at 37°C/24 h. The energy and macronutrient content of BC was Copyright © ESPGHAN and NASPGHAN. All rights reserved. 6 calculated using reported measurements, and the BC products were diluted in tap water to obtain isoenergetic products (~4,000 kJ/L) (19) . The products were stored at -20°C, and ensured to be homogenous and warmed to body temperature in a water bath before use. All animal procedures were approved by the Danish National Committee on Animal Experimentation (Licence: 2004/561-910).
Clinical evaluation, tissue collection and gut morphology
Pigs were monitored closely and euthanized if clinical symptoms of NEC such as abdominal distension, lethargy, cyanosis or bloody diarrhoea were observed. Pigs not showing clinical signs of NEC were euthanized after 45-50 h of enteral feeding, and only pigs that had received treatment diets were included in the study. Euthanasia and tissue collection were performed according to earlier described protocols (20) . The proximal, middle and distal small intestine, stomach and colon were evaluated for macroscopic lesions and assigned an NEC score from 1-6, where one was assigned to a normal region and six to a severely affected region with pneumatosis intestinalis and extensive haemorrhagic necrosis, as previously described (6) . Pigs with a score of ≥3 in any region were regarded as a case of NEC. The mean NEC score was calculated as the mean of the NEC score from the five regions. Samples from the small intestinal regions were immediately snap-frozen and stored at -80°C for immune and enzyme assays. Distal small intestinal samples were prepared for fluorescence in situ hybridisation (FISH) and morphology measurements (villus height and crypt depth), and the proportion of dry mucosa and circumference, of each small intestinal region, were measured as previously described (6, 21) .
Intestinal digestive capacity, absorption and permeability
Intestinal digestive capacity was measured in homogenized (see above) intestinal samples as hydrolytic activities expressed as Unit (U)/g of wet intestine of aminopeptidase A, aminopeptidase N, dipeptidyl-peptidase IV, lactase and maltase as previously described (22) . Trehalase activity was measured as described for lactase and maltase using 0.6 M D-(+)-trehalose dihydrate (Sigma-Aldrich, Brøndby, Denmark) as a substrate. For all enzymes, 1 U of enzymatic activity was equal to hydrolysis of 1 μmol substrate/min at 37°C. To test the intestinal absorption capacity, an oral bolus of 15 ml /kg BW of a 5% galactose solution was given before, 6 h and 30 h after enteral food introduction and blood was collected after 20 min and analysed as previously described (23) . For the latter two time points, the bolus was given at least 2.5 h after the previous feeding. To assess intestinal permeability, an oral bolus of 5% lactulose and 2% mannitol (15 ml/kg BW) was given 4 to 6 h prior to euthanasia, at which time, urine was collected and analysed as described previously (18) .
Small intestinal and plasma levels of immune genes and proteins
The concentration of IL-1β , IL-6, IL-8, and IL-10 in distal small intestinal samples (homogenised in 1% Triton X-100, 6 ml/g wet tissue) or plasma (sampled at euthanasia (6)) was determined using a multiplex bead based assay, with the addition of IL-1β to the assay, and using the same conditions as described for this cytokine (24) . The results were expressed relative to the total protein concentration in each sample, which was determined by spectrophotometry (E280). Serum amyloid A (SAA) plasma concentrations were determined using an ELISA kit according to the manufacturer's instructions (Tridelta Developments Ltd. Maynooth, County Kildare, Ireland). The gene expression of IL1B, IL6, IL8, TLR4, TNF, IL10, DEFB4A, SAA, and reference genes ACTB, B2M and HPRT1 in the distal small intestine was determined using reverse transcription real-time quantitative PCR as previously described, where also information on reference genes (B2M, ACTB, and HPRT1) and genes of interest can be found (6) . Gene expression differences were assessed by setting the mean for the COLOS group to one, and the mean of the gene in question from the other groups was displayed as relative expression, compared with the COLOS group.
Bacterial abundance, location and fermentation products
FISH was performed on formaldehyde-fixed distal small intestine sections using an AlexFluor555oligonucleotide general bacteria probe (5'-GCTGCCTCCCGTAGGAGT-3', Eurofins MWG Operon AG, Ebersberg, Germany) as previously described (6, 25) . The most representative crosssection from each pig was evaluated for bacterial abundance (score 1-5, where one correspond to no or very few microcolonies and 5 to extensive colonisation) and bacterial location (score 1-4, where one was assigned when the bacteria were only in the lumen and 4, when the bacteria were throughout the section and translocated to muscularis mucosae) as previously described (6) . As a marker of bacterial metabolic activity, the concentration of 15 organic acids (OA) in stomach and colon contents was measured as described previously, using one gram of sample in the extraction procedure (26) .
Migration of intestinal epithelial cells in vitro
A scratch wound assay was performed to quantify cell migration as described earlier (27) . and 5% CO2. Cells were incubated in 12-well plates (2 × 10 5 cells/well) overnight and a standardised cell-free area was made with a pipette tip. Cells were washed carefully with phosphate-buffered saline (Invitrogen) and incubated with 0-10% (v/v) whey from COLOS, POW and POWPAS in culture medium without FBS. Whey was prepared from COLOS (1:5 dilution), and POW or POWPAS (10%, v/v) as previously described (28) . The migration distance from the original wound border was determined by photomicrographs immediately after wounding and 5-6 h after.
Characterisation of some growth factors and proteins in BC products
The concentration of insulin-like growth factor (IGF-I), transforming growth factor (TGF)-β1 and TGF-β2 was determined in two replicate measurements by time-resolved immune-fluorescence assay (IGF-I) and ELISA (TGF-β1, TGF-β2) in whey fractions of COLOS, POW and POWPAS as previously described (28) . BC protein denaturation and aggregation were determined by SDS-PAGE analysis. Briefly, 1% (w/v) BC solutions were prepared and used without further treatment or centrifuged (15 min; 13,000g). Following centrifugation, the supernatants were sampled without disturbing the lipid layer. Samples were heated to 95°C for 3 min in non-reducing Laemmli sample buffer and then 11.25 µg of protein from each sample was applied to 12% Tris/Glycine SDS-PAGE gels and proteins separated using electrophoresis. Proteins were visualised by staining with Coomassie Brilliant Blue. The relative molecular weight of the proteins was determined by comparison to the migration of a molecular weight marker, See Blue (Invitrogen).
Statistical analyses
In the in vivo study, NEC incidence was analysed using Fisher's exact test, with subsequent pairwise comparisons. All other data were analysed using the parametric analysis of variance, ANOVA, either as the PROC MIXED model of SAS (v9.1, SAS Institute, NC, USA) with treatment and region as fixed variables (mean NEC score and enzyme activities) or treatment as fixed variable, and litter as random variable. Gene expression data were log2 transformed, and for all other data, in cases of non-normality, log10 transformation was done before analysis. Spearman correlation was performed in GraphPad Prism (v5.02; La Jolla, CA, USA), and the relationship between two variables were considered to correlate when Spearman's rho, ρ < -0.5 / > 0.5, equal to P < 0.001. Data are presented as mean with standard error of the mean (SEM) and P < 0.05 was used as the critical level of significance. Furthermore, for gene expression data a fold-change of ≥ 2 (linear scale) were defined as a cutoff for biological significance. In the in vitro study, the effect of 10 COLOS, POW and POWPAS whey on IEC-6 cells migration was analysed using the PROC MIXED procedure of SAS with whey and concentration as fixed variables and number of replicates/treatment (n = 12) as random variable. Values are presented as relative migration based on least-squares means + SEM, and P < 0.05 used as the critical level of significance.
Results
Clinical outcome, organ and intestinal dimensions
The mean NEC score was higher in FORM than in POWPAS and POW pigs, and in COLOS compared with POWPAS pigs (Figure 1a 
Intestinal digestive capacity, absorption and permeability
Across the small intestinal regions, the activity of five of six enzymes was higher in BC, compared with FORM pigs, while some differences were also observed among the BC pigs (Figure 1f-j) . The activity of trehalase was similar between groups (pooled values, 0.32 ± 0.01 U/g of wet intestine).
Galactose absorption did not differ between groups at 0 h and 6 h, but was higher at 30 h in BC than FORM pigs (Figure 2 ). No treatment effect was observed for the intestinal permeability measured as the ratio of lactulose to mannitol (pooled values, 0.08 ± 0.02).
Small intestinal and plasma levels of immune genes and proteins
The protein concentration of IL-1β and IL-8 in the distal small intestine was higher in FORM than in BC pigs (Figure 3a,b) . Furthermore, IL-1β correlated positively with the distal small intestinal NEC score (ρ = 0.50, P < 0.001) and with IL1B (ρ = 0.56, P < 0.001). In contrast, no significant correlations were found between IL-8 and IL8 or the distal small intestinal NEC score (not shown).
Plasma IL-10 (pooled values, 53.0 ± 5.5 pg/ml) and SAA (pooled values, 83 ± 11 μg/ml) levels were similar across groups, and did not correlate significantly with the mean NEC score (not shown). The concentrations of IL-6 and IL-10 in the distal small intestine, and plasma levels of IL-1β, IL-6, and IL-8, were generally below detection limit (data not shown).
In the distal small intestine, a moderately up-regulation of DEFB4A was observed in POWPAS, IL10, TLR4 and TNF did not differ between the groups (data not shown), but positive correlations were observed between the distal small intestinal NEC score and the expression of IL1B (ρ = 0.55, P < 0.001) and IL8 (ρ = 0.50, P < 0.001).
Bacterial abundance, location and fermentation products
FISH analyses of the distal small intestinal microbiota revealed no differences in bacterial location (pooled values, 2.0 ± 0.1) or abundance (pooled values, 2.0 ± 0.2) among the four groups. However, a positive correlation between the NEC score of the distal small intestine and the bacterial abundance score (ρ = 0.52, P < 0.001) was observed.
In the stomach, the major OA were acetic, butyric, lactic and octanoic acid, while acetic, butyric, formic and lactic acid dominated in the colon (Figure 4a,b) . In the stomach, the concentration of acetic and butyric acid was lower in FORM, relative to BC pigs, while octanoic acid was higher in 
Migration of intestinal epithelial cells in vitro
Increased migration of IEC-6 cells was observed with increasing concentration of COLOS and POWPAS whey, resulting in a maximum increase in the migration at 10%, relative to 0% whey. For POW whey, a maximum increase was observed at 1%, relative to 0% POW whey, while the migration decreased at 5% POW whey, and extensive cell lysis was observed at 10% (Figure 5a ). Within concentrations, an increased migration was observed at 0.01% COLOS, relative to POW and POWPAS whey. Furthermore, the migration was increased for COLOS, compared with POWPAS at 0.1% and 1% whey. Finally, at 5% whey the migration was decreased for POW, compared with COLOS and PASPOW (Figure 5b ).
Characterisation of growth factors and proteins in colostrum products
The IGF-I concentration was similar in COLOS, POW and POWPAS whey (pooled values, 1212 ± 26 ng/g dry matter). The concentration of TGF-β1 was higher in COLOS (35.1 ± 0.5 ng/g dry matter), compared with POW (18.7 ± 0.1 ng/g) and POWPAS (15.1 ± 0.4 ng/g), while the concentration of TGF-β2 was lower in POWPAS (166 ± 5 ng/g), compared with COLOS and POW (607 ± 5 and 558 ± 1 ng/g, respectively). Non-centrifuged samples had a similar protein profile on the SDS-PAGE gel ( Figure 6 ). Centrifugation resulted in removal of the majority of casein micelles (~36 kDa, average diameter 120-180 nm (29) ) in all BC products, while a smaller population of residual casein micelles (average diameter 60 nm (30)) remained. Qualitatively, protein aggregation was most pronounced in POWPAS, which was observed by a reduction in Ig (bands just below 250 kDa) and proteins in the region 64-98 kDa, including lactoferrin and lactoperoxidase (both observed at ~80 kDa). Still, all proteins of interest were detected also in POWPAS.
Discussion
Processing and sterilization of milk products reduce the content of milk bioactive factors, but the biological consequences of this are difficult to study in infants. We have previously shown that a raw BC product partially protects against NEC in preterm pigs (6, 18, 31) , and we now demonstrate that this protective effect remains after spray drying and pasteurisation of BC. Further studies are needed to show how processing conditions may affect the biological activity of BC products, especially since there was a tendency for the processed BCs in this study to be associated with slightly improved intestinal values, not only relative to formula, but also to untreated BC. While this would seem counter-intuitive, this is not impossible. The mild BC processing used in this study could potentially render some colostrum proteins more digestible for an immature gut, while retaining the major part of the beneficial bioactivity. The results from the in vivo study were supported by the in vitro study where increasing concentration of BC whey increased migration of intestinal epithelial cells, as a measure of wound healing properties. In this case, the best migration effect was seen with COLOS whey, and this ability of BC to stimulate cell migration and healing of epithelial wounds might be particularly important for the sensitive epithelium of preterm newborns.
In the in vitro study, the majority of parameters of intestinal structure and functions were improved to a similar extent across the three groups of BC-fed pigs, relative to pigs fed formula. A smaller intestinal circumference and increased villus height and distal small intestinal enzyme activity in the BC pigs indicate increased protection against loss of muscular tone, mucosal atrophy and brush-border enzyme dysfunction. Hexose absorptive function, measured by plasma galactose levels, decreased dramatically during the initial 6 h of formula feeding in all pigs, while it remains high when BC is fed immediately after TPN (6) . However, the mucosa regained its hexose absorptive capacity when the pigs subsequently were fed BC products, while the value remained low after continued formula feeding. Contrary to our earlier studies, all pigs in this study were fed a few boluses of formula after the TPN period and this initiates an intestinal inflammatory response, as shown previously (32) . It was therefore not surprising that we observed signs of inflammation in all three BC groups and higher NEC score/severity than in preterm pigs transitioned to colostrum products from birth or immediately after the TPN period (6, 18, 31) . Coupled with these previous observations, our results indicate that BC may work both as a preventive diet and a therapeutic diet to combat gut inflammatory processes in the immature intestine.
Colostrum feeding resulted in decreased IL-1β and IL-8 levels in the distal small intestinal tissue and thereby reversed the initial pro-inflammatory state induced by combined TPN and initial formula feeding. Sow's colostrum also down-regulate such inflammatory responses, as indicated by decreased IL-1β (33) , confirming that colostrum obtained from different species may exert similar effects on the immature intestine, at least in pigs. The BC-protective effects were less clear when measuring cytokine gene expression levels, compared with protein levels, at least for IL-1β and IL-8. A lack of consistency between cytokine mRNA and protein levels may be explained by a difference in the onset of the expression of a certain gene and the production and secretion of the protein that follows (34) . The correlation between the expression of IL1B and the distal small intestinal NEC score suggests a close relationship between the expression of this inflammatory mediator and the degree of intestinal inflammation, more than a relation with the type of diet. This is supported by a recent study that showed only four genes (DEFB1, CXCL10, IL1RN, and ALPI) of 48 genes to be differentially regulated between BC and FORM preterm pigs (35) . Similarly, the mucosal bacterial abundance in the distal intestine correlated positively with the NEC score in that region, but not with diet. This indicates that the density of the mucosal microbiota is not very diet-independent but more related to the progression of inflammation and tissue lesions (9, 36) . On the other hand, excessive fermentation in the colon lumen, especially indicated by increased lactate levels, was more prevalent in FORM pigs and this may play a separate role for increased inflammation in this group.
Interestingly, no differences in protein aggregation were observed between the COLOS and POW products indicating that the type of spray drying used in this study did not markedly damage the milk proteins. In contrast, pasteurisation resulted in a higher degree of protein aggregation and it also reduced the concentration of important milk bioactives, such as TGF-β2. Both spray drying and pasteurisation reduced the concentration of TGF-β1, while IGF-I was not affected by neither of the procedures. This suggests that a significant number of milk proteins remains unaffected by processing and may contribute to beneficial biological effects of processed BC on the immature intestine. The irradiation dose used in this study did not appear to lead to significant denaturation of BC proteins, which was indicated in a study comparing irradiated BC from this study and nonirradiated BC from the same pool of colostrum (unpublished results).
We conclude that spray dried and pasteurised BC improves gut function and NEC prevention in preterm pigs in the immediate postnatal period. Consequently, BC products may serve as valuable alternatives to infant formula and banked human donor milk during the first critical days after preterm birth, if mother's milk is not available. Potentially, such products may also serve to fortify mother´s milk or human donor milk with highly digestible and bioactive proteins. Studies on the efficacy of BC products to promote growth, food tolerance and NEC protection in the first few weeks of life for preterm infants are warranted. Copyright © ESPGHAN and NASPGHAN. All rights reserved. 
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